ProTEC-USA Announces Expanded Medical Gown Manufacturing Capabilities

ProTEC-USA has announced the debut of a new, state of the art production work cell that will expand and enhance its capacity to produce EZDoff medical gowns for healthcare and other critical industries.

A subsidiary of Troy, Michigan-based Cadillac Products, Inc., in-house extrusion, film converting and gown manufacturing capabilities from the company’s facilities in the USA allow ProTEC-USA to serve as a strategic, domestic supply chain partner, delivering high-quality gowns with volume-level pricing.

“COVID-19 exacerbated market demands that were already growing prior to the pandemic,” said Don Lowe, Spokesperson, ProTEC-USA. “This investment from the company in upgrades and enhancements to production lines and equipment will boost our capacity in order to better meet demand.

The new, proprietary work cell was completely designed and built inhouse, addressing all the needs for quality control and optimal cost. These gowns will be available in three color options—blue, yellow or white—and will also be available with level 1, 2 or 3 compliance, based on the depth of protective needs of the user.

“EZDoff gowns are designed to not only maintain effectiveness and mitigate potential self-contamination, but also to be mindful of the manner in which the gowns are donned and doffed in sequence with other PPE,” said Lowe. “Without touching the outside surface of the EZDoff gown to remove it, the wearer is protected against consequential contamination.”

EZDoff gowns offer several features and benefits for wearers, including:

Perforated rear yoke for safe, easy doffing of medical gowns
Sleeve with thumb loop for full arm and wrist protection, simultaneous glove donning
Apron closure to maintain the user’s coolness during work performance
Compliance with all AAMI and FDA specifications and requirements
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides our readership with breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

“We are excited to begin our journey as a public company with this additional investment. We believe Tevogen’s patient-centric approach, which merges a focus on affordability with advanced science, is a blueprint for sustainable success in the current era of healthcare. I am pleased that investors now have the opportunity to participate in Tevogen’s mission to become the very first life science company offering commercially attractive and affordable personalized T cell therapies for large patient populations in virology, oncology, and neurology, said the CEO of Tevogen Bio.
MB2 Dental notes the financing will be used to fund upcoming acquisitions and future growth for the company, following a record year of growth in 2023 with 150 new partnerships.
Procyrion notes the funding will support the DRAIN-HF pivotal IDE trial evaluating the company's Aortix pump, internal R&D programs to improve manufacturability, and commercialization preparation.
PhotoniCare, in January of this year, announced that the U.S. Food and Drug Administration had granted clearance for its TOMi™ Scope for non-invasive imaging of the middle ear.
Vicarious Surgical added Philip Liang and Ric Fulop to their Board of Directors. 

By using this website you agree to accept Medical Device News Magazine Privacy Policy